AP-325 in Subjects With Peripheral Post-surgical Neuropathic Pain
Clinical trial NCT04429919 · COMPLETED
Trial details
- NCT number
- NCT04429919
- Sponsor
- Algiax Pharmaceuticals GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-22
- Primary completion
- 2024-10-04
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.